March 9, 2018 10:03 AM EST
Financing
China

Hua Med­i­cine plans to join trendy Hong Kong IPO club, pitch­ing an of­fer­ing of up to $400M -- re­ports

Amber Tong

A di­a­betes drug mak­er that has at­tract­ed in­vest­ment from Arch Ven­ture Part­ners, Ven­rock and WuXi AppTec is the lat­est Chi­nese com­pa­ny plan­ning an IPO in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Am­gen’s once-a-month obe­si­ty shot shows 20% weight loss af­ter a year

Roche buys out CAR-T part­ner Po­sei­da for $1B up­front

Alec­tor says Alzheimer's pro­gram tar­get­ing mi­croglia fails Phase 2, stock dives

How did Trump’s FDA pick land? Biotech stocks are up, and ex­ec­u­tives are (most­ly) re­lieved

Trump team asked Warp Speed leader to head NIH, may seek more tra­di­tion­al pick for role

Roche’s TIG­IT drug miss­es last shot at sur­vival end­point win in Phase 3 lung can­cer tri­al

A service from the Financial Times